Patents Assigned to Integral Molecular, Inc.
-
Patent number: 12545726Abstract: The present disclosure describes compositions and methods related to GPRC5D binding agents.Type: GrantFiled: July 22, 2025Date of Patent: February 10, 2026Assignee: Integral Molecular, Inc.Inventors: Trevor Barnes, Hayley Roth, Joseph B. Rucker, Ross Chambers, Benjamin J. Doranz
-
Patent number: 12497450Abstract: Antibodies and compositions against Claudin 6 and uses thereof are provided.Type: GrantFiled: January 4, 2022Date of Patent: December 16, 2025Assignee: Integral Molecular, Inc.Inventors: Ross Chambers, Joseph Rucker, Thomas Charpentier, Lewis J. Stafford, Brad Screnci, Trevor Barnes, Benjamin Doranz
-
Patent number: 12428474Abstract: Peptides and uses thereof, such as a common light chain in an antibody, are provided.Type: GrantFiled: February 3, 2022Date of Patent: September 30, 2025Assignee: Integral Molecular, Inc.Inventors: Thomas Charpentier, Ross Stewart Chambers, Lewis J. Stafford, Trevor Barnes, Jonathan T. Sullivan
-
Patent number: 12049502Abstract: The disclosure is directed to an antibody specific for claudin 6 and CD3 and method of preparing and using the same. The present disclosure describes the isolation and characterization of antibodies, antibody fragments, and antibody variants specific for claudin 6 and CD3.Type: GrantFiled: November 29, 2023Date of Patent: July 30, 2024Assignee: Integral Molecular, Inc.Inventors: Joseph Rucker, Kyle Doolan
-
Patent number: 11834497Abstract: Antibodies and compositions against GLUT4 and uses thereof are provided herein.Type: GrantFiled: April 30, 2019Date of Patent: December 5, 2023Assignee: INTEGRAL MOLECULAR, INC.Inventors: David F. Tucker, Kimberly-Anne Mattia, Christine R. Fisher, Benjamin J. Doranz, Joseph B. Rucker
-
Patent number: 11254736Abstract: Peptides and uses thereof, such as a common light chain in an antibody, are provided.Type: GrantFiled: February 13, 2020Date of Patent: February 22, 2022Assignee: INTEGRAL MOLECULAR, INC.Inventors: Thomas Charpentier, Ross Chambers, Lewis J. Stafford, Trevor Barnes, Jonathan T. Sullivan
-
Patent number: 11248046Abstract: Antibodies and compositions against Claudin 6 and uses thereof are provided.Type: GrantFiled: February 13, 2020Date of Patent: February 15, 2022Assignee: Integral Molecular, Inc.Inventors: Ross Chambers, Joseph Rucker, Thomas Charpentier, Lewis J. Stafford, Brad Screnci, Trevor Barnes, Benjamin Doranz
-
Patent number: 11135280Abstract: Provided herein are methods of incorporating substitutions of specified residues into a filovirus GP in order to increase immunogenicity and/or broaden the cross-reactivity of the protective immune response against other filovirus members. Also provided herein are mutant filovirus GPs comprising such substitutions.Type: GrantFiled: March 27, 2017Date of Patent: October 5, 2021Assignees: INTEGRATED BIOTHERAPEUTICS, INC., INTEGRAL MOLECULAR, INC.Inventors: Mohammad Javad Aman, Katie A. Howell, Edgar Davidson, Benjamin J. Doranz
-
Patent number: 9902765Abstract: Embodiments disclosed herein provide for antibodies, including neutralizing antibodies, against Chikungunya virus, uses thereof, and methods of identifying antibodies, including neutralizing antibodies, against Chikungunya virus. In some embodiments, antibodies that binds to a CHIKV antigen, wherein the antigen is the CHIKV E1, E2, E3 protein, or any heterocomplex thereof are provided. In some embodiments, the antibody is an isolated antibody, a neutralizing antibody, a recombinant antibody, or any combination thereof. In some embodiments, the antibodies described herein bind to an epitope of E2 Domain A, E2 Domain B, or E1 Domain II of the CHIKV antigen. In some embodiments, the antigen is E2 protein.Type: GrantFiled: July 21, 2014Date of Patent: February 27, 2018Assignees: INTEGRAL MOLECULAR, INC., BLOOD SYSTEMS RESEARCH INSTITUTEInventors: Benjamin Doranz, Kimberly-Anne Mattia, Kristen Kahle, Graham Simmons, Rachel Hua-Ning Fong, Soma Banik Banerjee
-
Patent number: 9213027Abstract: The present invention relates to lipoparticles. The invention also relates to producing lipoparticles. The invention further relates to lipoparticles comprising a viral structural protein. The invention further relates to a lipoparticle comprising a membrane protein, and the lipoparticle can be attached to a sensor surface. The invention further relates to methods of producing and using the lipoparticle to, inter alia, assess protein binding interactions.Type: GrantFiled: November 1, 2013Date of Patent: December 15, 2015Assignee: Integral Molecular, Inc.Inventors: Benjamin J. Doranz, Sharon Willis
-
Publication number: 20140135230Abstract: The present invention relates to lipoparticles. The invention also relates to producing lipoparticles. The invention further relates to lipoparticles comprising a viral structural protein. The invention further relates to a lipoparticle comprising a membrane protein, and the lipoparticle can be attached to a sensor surface. The invention further relates to methods of producing and using the lipoparticle to, inter alia, assess protein binding interactions.Type: ApplicationFiled: November 1, 2013Publication date: May 15, 2014Applicant: Integral Molecular, Inc.Inventors: Benjamin J. Doranz, Sharon Willis
-
Patent number: 8691961Abstract: The present invention relates to the production and uses of flavivirus replicons and flavivirus particles and reporter virus particles. The present invention relates to the production and uses of chimeric and codon-optimized flavivirus virus replicons and flavivirus virus particles and reporter virus particles.Type: GrantFiled: November 9, 2010Date of Patent: April 8, 2014Assignee: Integral Molecular, Inc.Inventors: Bridget Puffer, Kimberly-Anne Mattia
-
Patent number: 8574590Abstract: The present invention relates to lipoparticles. The invention also relates to producing lipoparticles. The invention further relates to lipoparticles comprising a viral structural protein. The invention further relates to a lipoparticle comprising a membrane protein, and the lipoparticle can be attached to a sensor surface. The invention further relates to methods of producing and using the lipoparticle to, inter alia, assess protein binding interactions.Type: GrantFiled: July 28, 2004Date of Patent: November 5, 2013Assignee: Integral Molecular, Inc.Inventors: Benjamin J. Doranz, Sharon Willis, Eric Ross, Tiffani Anne Greene
-
Publication number: 20130244222Abstract: The present invention relates to the use of lipoparticles, virus-like particles, and viruses. The present invention also relates to testing ion channel function and modulators of ion channels.Type: ApplicationFiled: January 15, 2013Publication date: September 19, 2013Applicant: Integral Molecular, Inc.Inventor: Benjamin J. Doranz
-
Patent number: 8377691Abstract: The present invention relates to the use of lipoparticles, virus-like particles, and viruses. The present invention also relates to testing ion channel function and modulators of ion channels.Type: GrantFiled: January 25, 2007Date of Patent: February 19, 2013Assignee: Integral Molecular, Inc.Inventor: Benjamin J. Doranz
-
Publication number: 20110077163Abstract: The present invention relates to articles and methods for determining the function of genes, gene products, and nucleic acid products. The present invention also relates to identifying ligands and binding partners or proteins and nucleic acid products. The present invention also relates to methods and compositions related to reverse-transfection.Type: ApplicationFiled: September 28, 2010Publication date: March 31, 2011Applicant: INTEGRAL MOLECULAR, INC.Inventor: Benjamin Doranz
-
Publication number: 20080318208Abstract: The present invention relates to the production and uses of Dengue virus replicons and Dengue reporter virus particles. The present invention relates to methods of identifying inhibitors of Dengue virus infection, inhibitors of Dengue virus replication, and inhibitors of Dengue virus assembly.Type: ApplicationFiled: February 12, 2007Publication date: December 25, 2008Applicant: Integral Molecular, Inc.Inventors: Bridget Puffer, Benjamin J. Doranz
-
Publication number: 20070225227Abstract: The present invention relates to the use of lipoparticles, virus-like particles, and viruses. The present invention also relates to testing ion channel function and modulators of ion channels.Type: ApplicationFiled: January 25, 2007Publication date: September 27, 2007Applicant: Integral Molecular, Inc.Inventor: Benjamin Doranz